---
title: About
layout: default
permalink: /about2
---
       
# About
        
The Disease Maps Project as a large-scale community effort was initiated by the <a href="http://wwwen.uni.lu/lcsb" target="_blank">Luxembourg Centre for Systems Biomedicine</a>, the <a href="http://www.eisbm.org/" target="_blank">European Institute for Systems Biology and Medicine</a> and the <a href="http://www.institut-curie.org/" target="_blank">Institut Curie</a>.

## Get involved

We are actively expanding the list of diseases covered by the Disease Maps Project and are looking for new contributors interested in molecular mechanisms of diseases: computational biology teams working on disease models and clinicians or experimental biologists who would like to contribute as domain experts. If you are working on one of the diseases which are already listed on this website, please do not be discouraged: we would be happy to collaborate and integrate your work in the overall effort.  

## Project Leaders
        
<p>The leaders of the Disease Maps Project develop and refine the concept of disease maps, coordinate the activities of the community effort, help initiating new maps, advise on best practices and offer guidelines.</p>

<table>
<tr>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/AlexanderMazein.jpg" width="120"/></p></td>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/MarekOstaszewski1.jpg" width="120"/></p></td>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/InnaKuperstein.jpg" width="120"/></p></td>
</tr>
<tr>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Alexander Mazein, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">Senior Researcher, European Institute for Systems Biology and Medicine, France</p></td>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Marek Ostaszewski, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">Researcher, Luxembourg Centre for Systems Biomedicine</p></td>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Inna Kuperstein, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">ACSN Project Coordinator, Computational Systems Biology of Cancer group, Institut Curie, Paris, France</p></td>
</tr>
</table>    
        
## Disease Maps Scientific Committee

The repsonsibilities of the Disease Maps Scientific Committee are to help securing funding for the Disease Maps Project and to make sure that the effort progresses in a democratic and transparent manner. 

Principal Investigators of grants that support the Disease Maps developmnet can become members of the scientific committee. Invited members may be leading figures in the field of translational research. Joining of a new member requires uninamious support from current members. 

<table>
<tr>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/CharlesAuffray.jpg" width="120"/></p></td>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/ReinhardSchneider.jpg" width="120"/></p></td>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/EmmanuelBarillot.jpg" width="120"/></p></td>
</tr>
<tr>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Charles Auffray, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">Research Director at CNRS, Founding Director of the European Institute for Systems Biology and Medicine, Lyon, France</p></td>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Reinhard Schneider, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">Head of Bioinformatics Core, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg</p></td>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Emmanuel Barillot, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">Director of the U900 Institut Curie/INSERM/Ecole des Mines ParisTech, Paris, France</p></td>
</tr>
<tr>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/RudiBalling.jpg" width="120"/></p></td>
<td style="width: 200px;"><p style="margin:2px; text-align:left;"><img src="../images/teamhq/AndreiZinovyev.jpg" width="120"/></p></td>
<td style="width: 200px;"> </td>
</tr>
<tr>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Rudi Balling, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">Director, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg</p></td>
<td style="width: 200px; text-align:left; vertical-align:top;"><strong>Andrei Zinovyev, PhD</strong><p style="line-height:140%; margin-top:6px; font-size:13px;">Scientific Coordinator, Computational Systems Biology of Cancer group, Institut Curie, Paris, France</p></td>
<td style="width: 200px; text-align:left; vertical-align:top;"> </td>
</tr>
</table>    

<!--## Scientific Advisory Board
Jonathan Karr  
Gary Bader  
Henning Hermjakob  
David Nickerson  -->

## Acknowledgements

<!--<p>We would like to thank Rudi Balling, the Director of the <a href="http://lcsb.uni.lu" target="_blank">Luxembourg Centre for Systems Biomedicine</a> for his longstanding and enthusiastic support to the concept of disease maps. He is one of the key people that helped to catalyse the Disease Maps Project.</p>-->

<p>Most of the published disease maps were developed in collaboration with the <a href="http://www.sbi.jp/" target="_blank">Systems Biology Institute</a>, Tokyo, Japan (Mizuno et al., 2012, PMID <a href="https://www.ncbi.nlm.nih.gov/pubmed/22647208" target="_blank">22647208</a>; Matsuoka et al., 2013, PMID <a href="https://www.ncbi.nlm.nih.gov/pubmed/24088197" target="_blank">24088197</a>; Fujita et al., 2014, PMID <a href="https://www.ncbi.nlm.nih.gov/pubmed/23832570" target="_blank">23832570</a>; Kuperstein et al., 2015, PMID <a href="https://www.ncbi.nlm.nih.gov/pubmed/26192618" target="_blank">26192618</a>). We would like to underline the role of Prof. Hiroaki Kitano in pioneering the process description representation of signalling networks and initiating first comprehensive disease-relevant extensive reconstructions of signalling pathways (Oda et al., 2005, PMID <a href="https://www.ncbi.nlm.nih.gov/pubmed/16729045" target="_blank">16729045</a>; Oda and Kitano, 2006, PMID <a href="https://www.ncbi.nlm.nih.gov/pubmed/16738560" target="_blank">16738560</a>; Caron et al., 2010, PMID <a href="https://www.ncbi.nlm.nih.gov/pubmed/21179025" target="_blank">21179025</a>).</p>

## Funding

The Disease Maps Project is funded in part by [IMI eTRIKS nÂ°115446](http://www.imi.europa.eu/projects-results/project-factsheets/etriks)
([eTRIKS](https://www.etriks.org/), European Translational Information and Knowledge Management Services)
